The biopharmaceutical industry is undergoing a profound transformation through the development of targeted protein degradation as an innovative therapeutic strategy that challenges traditional drug development approaches. Proteolysis Targeting Chimeras (PROTACs) represent the vanguard of this medical innovation, providing extraordinary capabilities to systematically eliminate disease-causing...